SCHEMBL9923857

SCHEMBL9923857

CCOC(=O)N[C@H]1CC[C@H](N/C(=N\C(=O)c2ccc(F)c(F)c2)NCc2cccc(F)c2)CC1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CHRM1 P11229 1/20 0.40
POLB P06746 1/20 0.38
MAPK14 Q16539 1/20 0.38
DRD2 P14416 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38
ROCK2 O75116 2/20 0.37
ROCK1 Q13464 2/20 0.37
P2RY12 Q9H244 1/20 0.37
EPHX2 P34913 2/20 0.36
HTT P42858 1/20 0.36
NTRK1 P04629 2/20 0.36
S1PR3 Q99500 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924267 0.93 SMN1; SMN2 (0.47) LMNASMN1; SMN2CHRM1MAPK14ROCK2
SCHEMBL9924066 0.92 CHRM1 (0.41) LMNASMN1; SMN2CHRM1MAPK14HTT
SCHEMBL9923856 0.92 CHRM1 (0.42) LMNASMN1; SMN2CHRM1POLBMAPK14
SCHEMBL9924275 0.90 THRB (0.45) SMN1; SMN2CHRM1POLBMAPK14ROCK2
SCHEMBL9924063 0.88 SMN1; SMN2 (0.43) LMNASMN1; SMN2CHRM1MAPK14HTT
SCHEMBL9924273 0.88 CHRM1 (0.41) LMNASMN1; SMN2CHRM1POLBMAPK14
SCHEMBL9923859 0.88 CHRM1 (0.41) LMNASMN1; SMN2CHRM1POLBMAPK14
SCHEMBL9924429 0.87 NTRK1 (0.43) DRD2ADRA1DADRA1AADRA1BROCK2
SCHEMBL9924067 0.87 SMN1; SMN2 (0.43) LMNASMN1; SMN2CHRM1POLBMAPK14
SCHEMBL9923858 0.87 ALDH1A1 (0.41) LMNASMN1; SMN2CHRM1POLBMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed